Yakup Ergün: Adding LCT does not improve survival in oligometastatic NSCLC

Yakup Ergün, Medical Oncologist at Antalya City Hospital, recently shared a post on X:

“NRG-LU002: maintenance systemic therapy vs local consolidative therapy plus maintenance therapy in oligometastatic NSCLC.

90% having received IO-based therapy.

Adding LCT does not improve survival. It increases side effects.

Presented by Dr. Puneeth Iyengar.”

Source: Yakup Ergün/X